Enpro (NPO) Investor presentation summary

Strategy and portfolio

• 2025+ strategy targets mid-to-high single-digit organic growth, strong free cash flow, selective acquisitions and adjusted EBITDA margins above 25%.

• Portfolio transformation in 2019–2024 included 13 divestitures generating $1B and five acquisitions totaling $1.7B, shifting toward innovative industrial technology and recurring aftermarket revenue.

• Overlook adds single-use biopharma manufacturing technologies; Alpha adds liquid sensing and instrumentation. Both acquisitions were completed in 2025 and sit in Sealing Technologies.

Business mix and performance

• LTM revenue was $1.288B and adjusted EBITDA was $323.9M, a 25.1% margin; aftermarket represented 52% of LTM sales.

• LTM sales mix: Sealing Technologies 63%, Advanced Surface Technologies 37%; semiconductor 34%, general industrial 28%, commercial vehicle 13%, aerospace 8%, food and pharma 7%, power generation 5%, and oil and gas 5%.

• Q3 2026 Sealing Technologies sales were $214.7M versus $178.2M YoY; adjusted segment EBITDA margin was 32.6% versus 32.2%.

• Q3 2026 Advanced Surface Technologies sales were $136.5M versus $108.5M YoY; adjusted segment EBITDA margin was 25.1% versus 20.1%.

• Q3 2026 consolidated sales were $350.8M versus $286.6M YoY; adjusted EBITDA was $91.3M versus $69.3M.

Balance sheet and capital allocation

• Net leverage was approximately 1.4x at Q3 2026; liquidity included $83.4M cash and $715.2M available under the revolving credit facility.

• Nine-month 2026 free cash flow was $129.2M versus $104.9M in 2025; dividends paid were $20.6M.

• Capital allocation includes selective acquisitions, an $50M share repurchase authorization, and a 2026 quarterly dividend increase marking the 11th consecutive year of increases.